Two decades of innovation. Over 750,000 patients treated. Thousands of patients studied.
The AtriClip portfolio delivers proven safety, effectiveness, and reliability in left atrial appendage exclusion – backed by extensive clinical evidence.
Learn more about the global leader in LAAE at <a href='https://www.linkedin.com/feed/hashtag/?keywords=AATS2026&highlightedUpd…; target='_blank'>#AATS2026</a> (booth 402) or by visiting: <a href="https://okt.to/xusROK" target="_blank">https://okt.to/xusROK</a>
<a href='https://www.linkedin.com/feed/hashtag/?keywords=LAAExclusion&highlighte…; target='_blank'>#LAAExclusion</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=AtriClip&highlightedUpd…; target='_blank'>#AtriClip</a>
